Rachel Davenport is Co-founder and Director at AlphaBiolabs, the UK’s leading laboratory providing UKAS-accredited DNA, drug, and alcohol testing services for the legal sector. Since establishing the company in 2004, Rachel has continued to ensure that the range of services offered remain at the forefront of innovation and value, supporting family law professionals, social workers, and local authorities with court-approved solutions for family law cases.
For further information please contact AlphaBiolabs on 0333 600 1300, email media@alphabiolabs.com or visit www.alphabiolabs.co.uk
Rachel Davenport is Co-founder and Director at AlphaBiolabs, the UK’s leading laboratory providing UKAS-accredited DNA, drug, and alcohol testing services for the legal sector. Since establishing the company in 2004, Rachel has continued to ensure that the range of services offered remain at the forefront of innovation and value, supporting family law professionals, social workers, and local authorities with court-approved solutions for family law cases.
For further information please contact AlphaBiolabs on 0333 600 1300, email media@alphabiolabs.com or visit www.alphabiolabs.co.uk
A good book, a glass of chilled Albarino, and being creative for pleasure help Liz McGrath balance the rigours of complex bundles and being Head of Chambers
Firm welcomes director in its financial services financial regulatory team
Partner appointment in firm’s equity capital markets team
Walkers and runners will take in some of London’s finest views at the 16th annual charity event
Law school partners with charity to give free assistance to litigants in need
Could the Labour government usher in a new era for digital assets, ask Keith Oliver, head of international, and Amalia Neenan FitzGerald, associate, Peters & Peters, in this week’s NLJ
An extra bit is being added to case citations to show the pecking order of the judges concerned. Former district judge Stephen Gold has the details, in his ‘Civil way’ column in this week’s NLJ
The Labour government’s position on alternative dispute resolution (ADR) is not yet clear